Results 91 to 100 of about 44,340 (254)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Early menarche and teenager pregnancy as risk factors for morbid obesity among reproductive-age women: A case-control study

open access: yesClinics
OBJECTIVES: The aim of this study was to evaluate potential risk factors, including non-communicable diseases, for morbid obesity in women between 20 and 49 years of age.
Amanda Gonçalves Neves   +5 more
doaj   +1 more source

Patient‐ and Clinician‐Related Factors Associated With the Reduction in Opioid Use Among Adults With Chronic Non‐Cancer Pain: A Systematic Review

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo   +8 more
wiley   +1 more source

The role of endoscopy in bariatric surgery [PDF]

open access: yesEinstein (São Paulo), 2006
The widespread use of bariatric surgery is justified by its safetyand good results associated with the impact of these proceduresover the means of communication.
Marcelo Simas de Lima, Fauze Maluf Filho
doaj  

MORBID OBESITY

open access: yesBritish Journal of Anaesthesia, 1982
G, Routh, W L, Baird, J M, Reid
openaire   +2 more sources

The Prevention of Eating Disorders in Australian Adolescents: A Modeled Cost‐Effectiveness Study

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Prevention programs for eating disorders (EDs) have the potential to reduce the onset of these diseases and improve the mental health and well‐being of the general population. However, there is mixed evidence on whether routine implementation of such programs at the population level is cost‐effective.
Long Khanh‐Dao Le   +5 more
wiley   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu   +3 more
wiley   +1 more source

Association of single nucleotide variants of the TCF7L2, FABP2, FTO, DRD2, MC4R genes with morbid obesity in women

open access: yesОжирение и метаболизм
BACKGROUND: Obesity is a widespread disease associated with serious complications. Obesity is a risk factor for many chronic diseases. The most common type of obesity is polygenic obesity, the pathogenesis of which involves external and internal factors,
A. A. Ivanova   +6 more
doaj   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler   +4 more
wiley   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy